Cumberland Pharmaceuticals Receivables

Cumberland Pharmaceuticals (CPIX) currently reports a receivables of $13M as of June 2026. That compares with $10M in the prior-year period — up 30.1% year over year. Use the charts on this page to explore Cumberland Pharmaceuticals's receivables history and peer comparisons.

Cumberland Pharmaceuticals's receivables increased from $10M to $13M — a 30.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cumberland Pharmaceuticals reported $13M in receivables as of June 2026. That compares with $10M in the prior-year period — up 30.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $13M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cumberland Pharmaceuticals, and consider following CPIX for alerts when major investors trade the stock.

Cumberland Pharmaceuticals is classified in the Healthcare sector. On receivables, it currently shows $13M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CPIX with unrelated industries.